
|Articles|October 18, 2022
Decode Health Collaborates with Quest Diagnostics
Collaboration to promote drug and diagnostics R&D in the fields of metabolic disease and autoimmune neurology.
Advertisement
Decode Health has announced a new phase of its collaboration with Quest Diagnostics. In earlier phases of the collaboration, the two parties developed RNA (transcriptome) sequencing capabilities. In this latest phase, the parties have developed a platform for collecting and storing deidentified consented specimens from individuals participating in research.
Read more about the collaboration
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
2
Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work
3
ACT Brief: Efficacy Ceiling Breakthrough in Autoimmune Disease, Early-Career Retention and Burnout Prevention, and PRV Program Catalyzing Rare Disease Investment
4
The Career They Didn't Train For: Rethinking Early-Career Burnout in Clinical Research
5



